rs45567233
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001911.3(CTSG):āc.374A>Gā(p.Asn125Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0702 in 1,613,820 control chromosomes in the GnomAD database, including 4,534 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
NM_001911.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CTSG | NM_001911.3 | c.374A>G | p.Asn125Ser | missense_variant | 4/5 | ENST00000216336.3 | NP_001902.1 | |
CTSG | XM_011536499.2 | c.416A>G | p.Asn139Ser | missense_variant | 4/5 | XP_011534801.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CTSG | ENST00000216336.3 | c.374A>G | p.Asn125Ser | missense_variant | 4/5 | 1 | NM_001911.3 | ENSP00000216336 | P1 | |
CTSG | ENST00000552252.1 | n.855A>G | non_coding_transcript_exon_variant | 3/4 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0613 AC: 9313AN: 152004Hom.: 338 Cov.: 32
GnomAD3 exomes AF: 0.0801 AC: 20015AN: 249924Hom.: 953 AF XY: 0.0795 AC XY: 10744AN XY: 135070
GnomAD4 exome AF: 0.0711 AC: 103994AN: 1461698Hom.: 4192 Cov.: 34 AF XY: 0.0716 AC XY: 52067AN XY: 727142
GnomAD4 genome AF: 0.0613 AC: 9328AN: 152122Hom.: 342 Cov.: 32 AF XY: 0.0628 AC XY: 4675AN XY: 74388
ClinVar
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 28, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at